16.09.2025 • News

Ineos Inovyn Mothballing its Chloromethane Production Facility in France

Effective from September 1, Ineos Inovyn has mothballed its chloromethane production facility in Tavaux. It will be optimising its chloromethane production at Rosignano in Italy, to mitigate any impact to customers.

Ineos Inovyn site in Tavaux, France
Ineos Inovyn site in Tavaux, France
© Ineos

Ineos Inovyn announced today that it has idled its chloromethane production facility in Tavaux, France. The decision reflects persistently weak market demand, regulatory challenges, and increased operational and energy costs.

To help minimize any impact on customers, Ineos Inovyn will be optimizing chloromethane production at its Rosignano site in Italy.

Arnaud Valenduc, Ineos Inovyn’s Business Director, said, “Our industry continues to face difficult market dynamics and challenging energy costs, with European gas prices around three times higher than the US. To balance Ineos Inovyn’s operating rates with weak market demand, we have announced the decision to mothball our chloromethane production facility in Tavaux. We remain committed to supporting our customers.”

Established in 1930 and situated on an industrial site covering about 500 acres in the Dolois basin south of Dijon, Inovyn France produces VCM, chlorine, caustic soda, hydrogen, chlorine derivatives, and PVC. Equipped with the latest generation of membrane electrolysis cell room, Inovyn ships more than 1 million tons of chemicals to customers each year, including 260,000 tons of PVC. As one of the area’s major employers, Inovyn France is committed to staying competitive and providing a safe, rewarding work environment for its employees.

Company

Logo:

Ineos

38 Hans Crescent, Knightsbridge
SW1X 0LZ London
UK

Company contact







From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read